Unique ID issued by UMIN | UMIN000025616 |
---|---|
Receipt number | R000029203 |
Scientific Title | The validation study of the efficacy of surgical and endoscopic procedures for adiposity and related comorbidity. |
Date of disclosure of the study information | 2017/01/23 |
Last modified on | 2019/09/11 10:08:52 |
The validation study of the efficacy of surgical and endoscopic procedures for adiposity and related comorbidity.
The validation study of the efficacy of surgical and endoscopic procedures for adiposity and related comorbidity.
The validation study of the efficacy of surgical and endoscopic procedures for adiposity and related comorbidity.
The validation study of the efficacy of surgical and endoscopic procedures for adiposity and related comorbidity.
Japan |
Adiposity and related comorbidity.
Surgery in general |
Others
NO
Validate a weight-loss-effect of bariatric surgery and endoscopic intragastric balloon placement for obese patients that are resistant to medical therapy.
Efficacy
Absolute weight loss and excess-weight loss late.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Initially, all patients undergo are performed endoscopic intragastric balloon placement. After 6 moths from performing endoscopic intragastric balloon placement, patients that meet the following inclusion criteria will be performed bariatric surgery (ex. Laparoscopic Adjustable Gastric Banding, Laparoscopic Roux en Y gastric bypass and Laparoscopic Sleeve Gastrectomy).
20 | years-old | <= |
60 | years-old | > |
Male and Female
1. Body Mass Index > 35
2. Existence of disability in daily life.
3. Resistant to the medical therapy.
4. Have an ability to understand this trial and strong preference to enroll in this trial.
- Inclusion criteria for bariatric surgery -
After 6 moths from performing endoscopic intragastric balloon placement, patients that meet 1. and 2.
1) Poor response to the previous medical therapy because of the patients' poor compliance.
2) Unwilling to undergo surgery.
3) Obese due to psychiatric disorders.
4) Have cosmetic purpose to enroll in this trial.
30
1st name | Hirofumi |
Middle name | |
Last name | Kawakubo |
Keio University School of Medicine
Department of Surgery
160-8582
35 Shinanomachi, Shinjuku, Tokyo, JAPAN
03-3353-1211
hkawakubo@z3.keio.jp
1st name | Hirofumi |
Middle name | |
Last name | Kawakubo |
Keio University School of Medicine
Department of Surgery
160-8582
35 Shinanomachi, Shinjuku, Tokyo, JAPAN
03-3353-1211
hkawakubo@z3.keio.jp
Department of Surgery, Keio University School of Medicine
Department of Surgery, Keio University School of Medicine
Self funding
Keio University School of Medicine, Ethics Committee
35 Shinanomachi, Shinjuku, Tokyo, JAPAN
03-5363-3503
med-rinri-jimu@adst.keio.ac.jp
NO
2017 | Year | 01 | Month | 23 | Day |
Unpublished
Terminated
2009 | Year | 11 | Month | 18 | Day |
2009 | Year | 11 | Month | 18 | Day |
2009 | Year | 11 | Month | 18 | Day |
2019 | Year | 11 | Month | 30 | Day |
2017 | Year | 01 | Month | 11 | Day |
2019 | Year | 09 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029203